Susan E. Draheim

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

Richard W. Schevitz, Nicholas J. Bach, D. G. CARLSON et al. · Nature Structural & Molecular Biology · 1995 · 215 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides

Susan E. Draheim, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Medicinal Chemistry · 1996 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI

David W. Snyder, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 2. Effect of side-chain modification on in vitro activity and pharmacokinetic parameters

Robert J. Ternansky, Susan E. Draheim, Andrew Pike et al. · Journal of Medicinal Chemistry · 1993 · 72 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 1. Indole-3-acetamides

Robert D. Dillard, Nicholas J. Bach, Susan E. Draheim et al. · Journal of Medicinal Chemistry · 1996 · 70 citations

Life Sciences, Biochemistry, Pharmacology +14